check_circleStudy Completed

Hyperkinetic Syndrome

Bayer Identifier:

Trial_EXC009

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available
Effects of Lisuride and placebo in hyperkinetic children

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

7 - 15 Years
  • -

  • -

Trial summary

Enrollment Goal
54
Trial Dates
June 1975 - July 1976
Phase
Phase 3
Could I Receive a placebo
N/A
Products
Dopergin (Lisuride Hydrogen-Maleate, BAYR5936)
Accepts Healthy Volunteer
N/A

Trial design

Clinical study comparing the effects of Lisuride and placebo in hyperkinetic children
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to marketed products.